title: Guidance on switching away from Piportil Depot® (pipotiazine palmitate) injection.
authors.affiliation: Peter Haddad, University of Manchester, UK, Mark Taylor, University of Queensland, Australia and University of Edinburgh, UK, Maxine X Patel, David Taylor, King's College London, UK. Email: marktaylor2@nhs.net.
authors.forename: Peter
authors.initials: P
authors.lastname: Haddad
authors.affiliation: Peter Haddad, University of Manchester, UK, Mark Taylor, University of Queensland, Australia and University of Edinburgh, UK, Maxine X Patel, David Taylor, King's College London, UK. Email: marktaylor2@nhs.net.
authors.forename: Mark
authors.initials: M
authors.lastname: Taylor
authors.affiliation: Peter Haddad, University of Manchester, UK, Mark Taylor, University of Queensland, Australia and University of Edinburgh, UK, Maxine X Patel, David Taylor, King's College London, UK. Email: marktaylor2@nhs.net.
authors.forename: Maxine X
authors.initials: MX
authors.lastname: Patel
authors.affiliation: Peter Haddad, University of Manchester, UK, Mark Taylor, University of Queensland, Australia and University of Edinburgh, UK, Maxine X Patel, David Taylor, King's College London, UK. Email: marktaylor2@nhs.net.
authors.forename: David
authors.initials: D
authors.lastname: Taylor
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000600:supply & distribution*; D003692:Delayed-Action Preparations; D057915:Drug Substitution; D006801:Humans; D010640:Phenothiazines / Q000008:administration & dosage / Q000600:supply & distribution*; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010640:Phenothiazines; C084607:pipothiazine palmitate